NL
GILD icon

NKCFO LLC’s Gilead Sciences GILD Stock Holding History

NKCFO LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-60,650
Closed -$7.44M – 112
2025
Q4 		$7.44M Sell
60,650
-1,635
-3% -$199K 2.15% 14
2025
Q3 		$6.91M Buy
62,285
+18,140
+41% +$2.06M 2.08% 12
2025
Q2 		$4.89M Hold
44,145
– – 2.04% 13
2025
Q1 		$4.95M Buy
44,145
+14,490
+49% +$1.5M 2.3% 10
2024
Q4 		$2.74M Buy
+29,655
New +$2.67M 1.2% 19

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NKCFO LLC's GILD Position: Q1 2026 in Review

NKCFO LLC sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 60,650 shares — an estimated $7.44M sold.

NKCFO LLC first reported a position in GILD in Q4 2024 and held it in 5 quarters. The position peaked at $7.44M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • NKCFO LLC reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • NKCFO LLC sold 60,650 Gilead Sciences shares in Q1 2026, an estimated $7.44M.
  • NKCFO LLC first reported a position in Gilead Sciences in Q4 2024 and held it in 5 quarters.
  • NKCFO LLC's Gilead Sciences position peaked at $7.44M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on NKCFO LLC's 13F filing for Q1 2026, filed 11 May 2026.